Jozsef Bukszár

MBD-seq as a cost-effective approach for methylome-wide association studies: demonstration in 1500 case--control samples.

Daniel Adkins, Patrick F Sullivan, Christina M Hultman, 2012, Epigenomics.

SNP-based analysis of neuroactive ligand–receptor interaction pathways implicates PGE2 as a novel mediator of antipsychotic treatment response: Data from the CATIE study

Daniel E. Adkins, J. Bukszár, J. McClay, 2012, Schizophrenia Research.

Genome-Wide Pharmacogenomic Study of Neurocognition As an Indicator of Antipsychotic Treatment Response in Schizophrenia

Jeffrey A Lieberman, Patrick F Sullivan, Robert E Vann, 2011, Neuropsychopharmacology.